EP Biocomposites

Why is EP Biocomposites Ltd falling/rising?

As of 25-Jun, EP Biocomposites Ltd's stock price has risen to 99.00, reflecting a 16.27% increase and outperforming its sector by 17.02%. Increased investor participation and trading above moving averages suggest a positive short-term trend.

As of 25-Jun, EP Biocomposites Ltd is experiencing a rise in its stock price, currently at 99.00, which reflects an increase of 13.85 or 16.27%. This upward movement is notable as the stock opened with a gain of 16.27% today and reached an intraday high of Rs 99. The performance today indicates that the stock has outperformed its sector by 17.02%. Additionally, there has been a rise in investor participation, with a delivery volume increase of 25% compared to the 5-day average, suggesting growing interest among investors. <BR><BR>Despite some erratic trading, where the stock did not trade on 3 out of the last 20 days, the current trading activity shows that the stock has maintained its price without fluctuation since opening. The stock is trading higher than its 20-day and 50-day moving averages, which may indicate a positive trend in the short term. Overall, these factors contribute to the stock's rise on this particular day.

Which are the latest news on EP Biocomposites?

What does EP Biocomposites do?

EP Biocomposites Ltd manufactures fibre reinforced polymer products and bio toilet solutions, classified as a Micro Cap company with a market cap of INR 16 Cr. The company was incorporated in 2020 and took over M/s. OM Ventures in 2021, with no recent sales or profit data reported.

Overview:<BR>EP Biocomposites Ltd is engaged in the manufacture of fibre reinforced polymer products and bio toilet solutions, operating within the Other Utilities industry and classified as a Micro Cap company.<BR><BR>History:<BR>EP Biocomposites Limited was incorporated as a Public Limited Company on January 17, 2020. The company underwent a significant change when it took over the running business of M/s. OM Ventures through a Business Takeover Agreement dated August 31, 2021. There is no recent sales or profit data reported.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: N/A<BR>Most recent Net Profit: N/A<BR>Market-cap value: INR 16 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 11.00<BR>Industry P/E: N/A<BR>Dividend Yield: 0.00%<BR>Debt-Equity: 0.26<BR>Return on Equity: 13.67%<BR>Price to Book: 1.50<BR><BR>Contact Details:<BR>Registrar Address: Not available.

How big is EP Biocomposites?

As of 10th June, EP Biocomposites Ltd has a market capitalization of 16.00 Cr, classifying it as a Micro Cap company, with Shareholder's Funds of 10.59 Cr and Total Assets of 16.61 Cr reported as of March 2025. There is no valid financial data available for Net Sales or Net Profit for the latest four quarters.

As of 10th June, <BR><BR>Market Cap: EP Biocomposites Ltd has a market capitalization of 16.00 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: There is no valid financial data available for Net Sales or Net Profit for the latest four quarters.<BR><BR>Balance Sheet Snapshot: The latest reporting period is March 2025, with Shareholder's Funds amounting to 10.59 Cr and Total Assets valued at 16.61 Cr.

Who are in the management team of EP Biocomposites?

The management team of EP Biocomposites includes Rajkumar Kamat (Managing Director), Leena Kamat (Director), Shreyas Nadkarni (Director), Nitin A Kunkolienker (Independent Director), and Dinesh Shenoy (Independent Director).

The management team of EP Biocomposites includes the following individuals:<BR><BR>1. Rajkumar Kamat - Managing Director<BR>2. Leena Kamat - Director<BR>3. Shreyas Nadkarni - Director<BR>4. Nitin A Kunkolienker - Independent Director<BR>5. Dinesh Shenoy - Independent Director<BR><BR>If you need more information about their roles or the company, feel free to ask!

Who are the peers of the EP Biocomposites?

EP Biocomposites' peers include Antony Waste, Eco Recyc., JITF Infra Logis, and others, with varying management and growth risks. Eco Recyc. shows the highest 1-year return at -30.23%, while EP Biocomposites has a better return of -19.04%.

Peers: The peers of EP Biocomposites are Antony Waste han, Eco Recyc., JITF Infra Logis, Denta Water, Concord Enviro, VVIP Infratech, Organic Recyclin, Gem Enviro, Filtra Consult., and Race Eco.<BR><BR>Quality Snapshot: Excellent management risk is observed at VVIP Infratech and Filtra Consult., while Average management risk is found at Antony Waste han, Eco Recyc., Denta Water, and EP Biocomposites. Below Average management risk is noted for Concord Enviro and Organic Recyclin, while JITF Infra Logis does not qualify. In terms of Growth, Excellent growth is seen at Eco Recyc. and Organic Recyclin, Good growth at VVIP Infratech, and Average growth at EP Biocomposites. Below Average growth is reported for Antony Waste han, Denta Water, Concord Enviro, Gem Enviro, and the rest. Capital Structure ratings show Excellent at Eco Recyc. and Organic Recyclin, Good at VVIP Infratech and Filtra Consult., Average at EP Biocomposites and Antony Waste han, and Below Average at Concord Enviro and Race Eco.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Eco Recyc. at -30.23%, while Concord Enviro has the lowest at -57.38%. EP Biocomposites' 1-year return of -19.04% is better than both. Additionally, peers with negative six-month returns include Denta Water, Concord Enviro, Gem Enviro, Filtra Consult., and Race Eco.

When is the next results date for EP Biocomposites Ltd?

The next results date for EP Biocomposites Ltd is 26 May 2026.

The next results date for EP Biocomposites Ltd is scheduled for 26 May 2026.

Is EP Biocomposites overvalued or undervalued?

As of November 19, 2025, EP Biocomposites is considered overvalued with a PE ratio of 15.35, an EV to EBIT of 11.15, and a year-to-date return of -45.03%, significantly underperforming compared to its peers and the Sensex.

As of 19 November 2025, EP Biocomposites has moved from a fair valuation to an expensive rating. The company is currently considered overvalued based on its financial metrics. Key ratios include a PE ratio of 15.35, an EV to EBIT of 11.15, and a ROCE of 12.38%. <BR><BR>In comparison to its peers, EP Biocomposites' PE ratio is significantly lower than that of Altius Telecom, which has a PE of 51.84, indicating that EP Biocomposites is not positioned favorably within its industry. Additionally, the company's recent stock performance has lagged behind the Sensex, with a year-to-date return of -45.03% compared to the Sensex's 9.02%, further reinforcing the notion that the stock is overvalued.

How has been the historical performance of EP Biocomposites?

EP Biocomposites has shown steady growth in net sales and profitability from Mar'21 to Mar'25, with net sales increasing from 2.95 Cr to 12.01 Cr and profit after tax rising from 0.36 Cr to 1.03 Cr, despite fluctuations in raw material costs and stagnant cash flow. Total assets and liabilities also grew significantly during this period.

Answer:<BR>The historical performance of EP Biocomposites shows a progressive increase in net sales and profitability over the years, with notable fluctuations in certain metrics.<BR><BR>Breakdown:<BR>EP Biocomposites has demonstrated a steady growth in net sales, rising from 2.95 Cr in Mar'21 to 12.01 Cr in Mar'25. The total operating income followed a similar trend, increasing from 2.95 Cr in Mar'21 to 12.01 Cr in Mar'25. However, the raw material costs also escalated, reaching 7.98 Cr in Mar'25 from 1.79 Cr in Mar'21. Operating profit, excluding other income, improved from 0.46 Cr in Mar'21 to 1.78 Cr in Mar'25, while the overall operating profit, including other income, increased from 0.46 Cr to 1.89 Cr in the same period. Profit before tax peaked at 1.42 Cr in Mar'25, although it slightly declined from 1.57 Cr in Mar'24. Profit after tax also saw growth, reaching 1.03 Cr in Mar'25 compared to 0.36 Cr in Mar'21. The company's total assets increased significantly from 0.55 Cr in Mar'20 to 16.61 Cr in Mar'25, alongside total liabilities which rose from 0.55 Cr to 16.61 Cr. Cash flow from operating activities remained stagnant at 0.00 Cr in Mar'25, while cash and cash equivalents at the end of the period were stable at 1.00 Cr. Overall, EP Biocomposites has shown resilience and growth in its financial performance over the years, despite some fluctuations in profit margins and cash flow.

Who are the top shareholders of the EP Biocomposites?

The top shareholder of EP Biocomposites is Leena Rajkumar Kamat, holding 64.93% of the shares, with no pledged holdings. The highest public shareholder is Sambhav Dawar at 1.04%, while individual investors collectively own 26.41%.

The top shareholders of EP Biocomposites include the promoters, with Leena Rajkumar Kamat holding the largest share at 64.93%. There are no pledged promoter holdings, and the company does not have any mutual funds or foreign institutional investors (FIIs) holding shares. The highest public shareholder is Sambhav Dawar, who owns 1.04%. Additionally, individual investors collectively hold 26.41% of the shares.

What is the technical trend for EP Biocomposites?

As of June 4, 2025, EP Biocomposites exhibits a mildly bearish technical trend, influenced by bearish moving averages and Bollinger Bands, despite mixed signals from the MACD and KST indicators.

As of 4 June 2025, the technical trend for EP Biocomposites has changed from does not qualify to mildly bearish. The weekly MACD indicates a mildly bullish stance, but the monthly MACD is mildly bearish, suggesting mixed signals. The Bollinger Bands and moving averages both show a mildly bearish trend on the weekly and daily time frames. The KST is bearish on the weekly, reinforcing the overall bearish sentiment. The Dow Theory indicates a mildly bearish trend on the weekly, with no trend on the monthly. Overall, the current technical stance is mildly bearish, driven primarily by the moving averages and Bollinger Bands.

Has EP Biocomposites declared dividend?

No Dividend History Available